Messenger RNA–based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the ...
While the Nobel-winning genome-editing technology CRISPR holds great promise, Duke’s Center for Advanced Genomic Technologies is putting some eggs in other baskets.
In trials of the new protocol, christened 20ExM, the project was able to image synaptic nanocolumns within brain cells, the clusters of proteins arranged in a specific way at synapses that allow ...
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (ALS), are characterized by the progressive loss of structure and function of neurons, ...